In fiscal year 2024, the report found, NIH awarded more than $36.9 billion to researchers, supporting more than 408,000 jobs and generating over $94.5 billion in new economic activity nationwide.
#Science2Startup is an opportunity for #lifescience researchers to showcase their startup ideas and network with top #biotech and #pharma execs, VCs and entrepreneurs in the Boston area. Applications are due December 5, 2022 - submit your idea today!
https://t.co/BL3EZn1k41
The #GoodwinLifeSciences team is excited to welcome partner Scott Bluni. He is joined by a team including counsel Matt Fagan and Kevin Canning, senior attorney Martin Miller, and five #intellectualproperty operations professionals. Read more: https://t.co/d0q3suqLsO #goodwinlaw
Thank you @Kayo_Conference for recognizing #GoodwinFDA and #GoodwinLifeSciences partners Julie Tibbets and Deepa Rich as industry trailblazers in this year's "22 in ’22 Women in Life Sciences"! View the full list and report here: https://t.co/NmhBvZ2Dof
.@usnews - Best Lawyers “Best Law Firms” has named #GoodwinLaw#Biotechnology Law Firm of the Year. The publication also acknowledged the firm across 49 practice areas, 41 national categories and 80 regional categories in the 2022 edition of the guide. https://t.co/PcRocOjA8K
Pleased to welcome partner Marie Fillon to our #LifeSciences practice in #GoodwinParis. Marie advises clients on #intellectualproperty agreements & intellectual property-related issues in connection with M&A and private equity transactions. Learn more: https://t.co/fTv6RKX1oU
The #GoodwinParis#Technology and #LifeSciences team advised Cathay Health (affiliated with @CathayCapital) on the €50 million Series C financing round of Tissium, a privately-owned #medtech company based in Paris and Boston. Click below for more details: https://t.co/k0Mhruc6Kw
The #GoodwinLifeSciences team advised Laronde @endlessRNA, on its $440M Series B Financing to advance the development of its #eRNA platform & a broad pipeline of programs across therapeutic categories. Get more on the financing now at the link: https://t.co/rPlRlB9H40 #biotech
We’re pleased to welcome #LifeSciences partner Kristin Havranek to Goodwin's West Coast team. Her practice focuses on patent prosecution and technology counseling, with an emphasis on the medical device industry. Find out more about Kristin here: https://t.co/BnuvpzJ32D
Pleased to note that the recently released H1 2021 Global #LeagueTables highlight Goodwin’s standing as the #1 legal advisor (by Deal Count) for Global & U.S. M&A deals. Get the details at the link: https://t.co/DWgl0ODxvT #mergersandacquisitions
Curious about what it takes to become a successful #lifesciences lawyer? Find out what these #GoodwinLifeSciences partners have to say about their area of specialization & why they enjoy what they do in this article published in @ChambersAssoc: https://t.co/B9vF1cA8IQ #lawcareers
The #GoodwinLifeSciences team advised @NimbusTx on the closing of a $105M private financing round which was led by BVF Partners L.P. with participation from existing investors including RA Capital Management and Atlas Venture. Learn more now at the link: https://t.co/TXSwgAehGm
The #GoodwinLifeSciences team advised Prime Medicine, Inc.™ on its launch and funding rounds totaling $315M. Read more about the launch and funding at the link: https://t.co/la4JG1AuN3 #genetherapy#geneediting
Congrats to our longtime client MyoKardia on its definitive merger agreement to be acquired by Bristol Myers Squibb for $13.1 billion. #Goodwinlaw team was led by Stuart Cable, Lisa Haddad, Mitchell Bloom, Michael Patrone & Maggie Wong. Full team & details https://t.co/7PNM3EfRuZ
AbCellera is thrilled to be featured as one of the Fierce 15 biotech companies of 2020! Thank you to @FierceBiotech for recognizing us and congratulations to all the companies in this year's impressive line up. #Fierce15
https://t.co/yLYDC27xZw